Key Insights

Highlights

Related Conditions

Often studied with 15 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT02979951Recruiting

Fosfomycin I.v. for Treatment of Severely Infected Patients

Showing all 1 trials

Research Network

Active Sponsors

  • Dr. Oestreich + Partner GmbH1
  • INPADS GmbH1
  • Infectopharm Arzneimittel GmbH1

Top Investigators

Related Conditions

  • Bacteremia1
  • Bone Diseases Infectious1
  • Pneumonia Bacterial1
  • Soft Tissue Infections1
  • Intraabdominal Infections1

Activity Timeline